Medical Properties TrustFRA:M3P -1.51%64 EBITDA Margin % is 80.67% as of Mar. 2026, which is 8% below its 10-year median of 87.74. GuruFocus rates FRA:M3P with a GF Score™ of 64/100 and a GF Value™ of €4.88 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 749 REITs companies, Medical Properties Trust ranks worse than 53.94% on this metric.
Medical Properties Trust (FRA:M3P) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Medical Properties Trust EBITDA Margin % Related Terms
Medical Properties Trust EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3P vs NHI, DHC, LTC: EBITDA Margin % Comparison
For the REIT - Healthcare Facilities subindustry, Medical Properties Trust's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medical Properties Trust EBITDA Margin % vs REITs Industry
For the REITs industry and Real Estate sector, Medical Properties Trust's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Medical Properties Trust's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Properties Trust (FRA:M3P) has a EBITDA Margin % of 80.67% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Properties Trust and its competitors. This is near median its historical median of 87.74. Over the past decade, Medical Properties Trust's EBITDA Margin % has ranged from 55.39 to 91.84. According to the industry distribution chart, Medical Properties Trust ranks #404 out of 749 companies in the REITs industry, placing it in the top 53.9%.
Is Medical Properties Trust's EBITDA Margin % too high?
Medical Properties Trust's current EBITDA Margin % of 80.67% is near median its 10-year median of 87.74. Over the past 10 years, this metric has ranged from a low of 55.39 to a high of 91.84. The REITs industry median EBITDA Margin % is 69.63. Medical Properties Trust's value of 80.67% is 15.9% above this industry median. Based on the distribution chart, Medical Properties Trust ranks #404 out of 749 companies in the REITs industry, which is below the industry midpoint. Overall, Medical Properties Trust has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Properties Trust's EBITDA Margin % compare to NHI and DHC?
According to the REITs industry distribution chart, Medical Properties Trust ranks #404 out of 749 companies for EBITDA Margin %. This places Medical Properties Trust in the lower half of its industry. The industry median EBITDA Margin % is 69.63. Medical Properties Trust's value of 80.67% is 15.9% above this benchmark. Historically, Medical Properties Trust's own EBITDA Margin % has ranged from 55.39 to 91.84 over the past decade. While the company's 10-year median is 87.74 vs. the industry median of 69.63, Medical Properties Trust has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a REITs company?
The median EBITDA Margin % among REITs companies is 69.63, based on 749 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Properties Trust's current EBITDA Margin % of 80.67% is 15.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Medical Properties Trust and its competitors. For the REITs industry, the median EBITDA Margin % is 69.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Properties Trust's current EBITDA Margin % is 80.67%, which is near median its own 10-year median of 87.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Properties Trust stock overvalued right now?
Based on GuruFocus' analysis, Medical Properties Trust (FRA:M3P) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.88, compared to a current price of €3.90 — trading 20% below its estimated fair value. The current EBITDA Margin % is 80.67%, which is near median its 10-year median of 87.74 and 15.9% above the REITs industry median of 69.63. Medical Properties Trust's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Medical Properties Trust (FRA:M3P), the current EBITDA Margin % is 80.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Properties Trust (FRA:M3P) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Properties Trust stock appears to be undervalued.
The current stock price of €3.90 is trading 20% below its estimated GF Value™ of €4.88.
GuruFocus considers Medical Properties Trust to be Modestly Undervalued.
Key valuation signals for FRA:M3P:
EBITDA Margin %: 80.67% (near median its 10-year median of 87.74)
GF Value™: €4.88 vs. price of €3.90 (20% below fair value)
Industry Position: 15.9% above the REITs median (#404 of 749)
No single metric tells the full story. See the FRA:M3P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.
64GF Score
Get the complete analysis for FRA:M3P
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3P has been successfully added to your 
